PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[TechandBio]

"The efficacy is there.. facts! Just as effective as Fabrazyme and more effective than Replagal (I believe will show LT superiority to Fabrazyme in efficacy as well)

Fewer premeds needed
Fewer reactions
Fewer AEs
Fewer ADAs
Potentially 50%+ fewer infusions
No risk of contamination and drug shortages, unlike FAB and REP

97% retention rate on switch over trials patients wanted to stay on PLX 102 three phase trials 3 completed The Fabry community is relatively small and well connected. Don’t think for a minute that they don’t understand these benefits and hear these testimonials. Most are eagerly awaiting its approval" Also the platfrom has been validated as Pfizer partnered with them for FDA approved drug for gaucher.

$PLX
$SNY
$PFE
$TAK